Podophyllotoxin phospholipid compound as well as pharmaceutical composition and application of podophyllotoxin phospholipid compound

The invention discloses a podophyllotoxin phospholipid compound as well as a pharmaceutical composition and application of the podophyllotoxin phospholipid compound. The pharmaceutical composition comprises a podophyllotoxin phospholipid compound or a combined pharmaceutical composition of the podop...

Full description

Saved in:
Bibliographic Details
Main Authors LING LONGBING, LI XINSONG, HE RUIYU, FANG SHUO
Format Patent
LanguageEnglish
Published 11.11.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses a podophyllotoxin phospholipid compound as well as a pharmaceutical composition and application of the podophyllotoxin phospholipid compound. The pharmaceutical composition comprises a podophyllotoxin phospholipid compound or a combined pharmaceutical composition of the podophyllotoxin phospholipid compound and a pharmacologically-acceptable carrier and is a liquid preparation, a solid preparation, a semi-solid preparation, a capsule, granules, gel and an injection. The pharmaceutical composition is a liposome nanoparticle (with the particle size of 10-1000nm) prepared from the podophyllotoxin phospholipid compound or the podophyllotoxin phospholipid compound and an adjuvant. The podophyllotoxin phospholipid compound and the liposome nanoparticle thereof can be used as liquid preparations, solid preparations, semi-solid preparations, disinfection preparations and sterile preparations, are low in toxicity and can be used for efficiently treating tumors.
Bibliography:Application Number: CN20151297973